Abstract:The aim of this review was to provide an update on the potential of cell therapies to restore or replace damaged and/or lost cells in retinal degenerative and optic nerve diseases, describing the available cell sources and the challenges involved in such treatments when these techniques are applied in real clinical practice. Sources include human fetal retinal stem cells, allogenic cadaveric human cells, adult hippocampal neural stem cells, human CNS stem cells, ciliary pigmented epithelial cells, limbal stem cells, retinal progenitor cells (RPCs), human pluripotent stem cells (PSCs) (including both human embryonic stem cells (ESCs) and human induced pluripotent stem cells (iPSCs)) and mesenchymal stem cells (MSCs). Of these, RPCs, PSCs and MSCs have already entered early-stage clinical trials since they can all differentiate into RPE, photoreceptors or ganglion cells, and have demonstrated safety, while showing some indicators of efficacy. Stem/progenitor cell therapies for retinal diseases still have some drawbacks, such as the inhibition of proliferation and/or differentiation in vitro (with the exception of RPE) and the limited long-term survival and functioning of grafts in vivo. Some other issues remain to be solved concerning the clinical translation of cell-based therapy, including (1) the ability to enrich for specific retinal subtypes; (2) cell survival; (3) cell delivery, which may need to incorporate a scaffold to induce correct cell polarization, which increases the size of the retinotomy in surgery and, therefore, the chance of severe complications; (4) the need to induce a localized retinal detachment to perform the subretinal placement of the transplanted cell; (5) the evaluation of the risk of tumor formation caused by the undifferentiated stem cells and prolific progenitor cells. Despite these challenges, stem/progenitor cells represent the most promising strategy for retinal and optic nerve disease treatment in the near future, and therapeutics assisted by gene techniques, neuroprotective compounds and artificial devices can be applied to fulfil clinical needs.

Translation of stem-cell-based therapies for retinal degeneration

Stem Cells for the Treatment of Neurodegenerative Diseases

Stem Cells in Central Nervous System Diseases: Promising Therapeutic Strategies.

Stem/progenitor cells and biodegradable scaffolds in the treatment of retinal degenerative diseases.

Stem/progenitor Cell-Based Transplantation for Retinal Degeneration: a Review of Clinical Trials.

Stem cell-based therapies for retinal diseases: focus on clinical trials and future prospects

Exploring Stem-Cell-Based Therapies for Retinal Regeneration

Advances of Stem Cell Transplantation in the Treatment of Retinal Degeneration

Research Progress of Stem Cell-Derived RPE Cell Transplantation Therapy for Retinal Degenerative Diseases

Progress of stem/progenitor cell-based therapy for retinal degeneration

Mesenchymal Stem Cell Transplantation for Retinal Degenerations and Dystrophies: Present and Future

Towards Stem/Progenitor Cell-Based Therapies for Retinal Degeneration

Novel Strategies for the Improvement of Stem Cells' Transplantation in Degenerative Retinal Diseases

Progress in stem cell transplantation for treatment of retinal ganglion cell damage diseases

Stemming retinal regeneration with pluripotent stem cells

Progress in Photoreceptor Replacement Therapy for Retinal Degenerative Diseases

Recent research advanceces in neural retina remodeling in vitro and degenerative eye disease

The advancement of the study in retinal disease treatment with stem cells therapy

Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges

Progress of stem cells applications in retina repair

Cell Therapy for Retinal Degenerative Diseases: Progress and Prospects